WebDisclosure WebDisclosure
Basculer en Français
11364 Companies
252471 Keywords
181962 Articles
138269 Press releases
Headlines Articles Press releases EMBARC Remove
  1. Home
  2. Companies
  3. EMBARC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/25/2026 at 11:10, 4 months 22 days ago

    EMBARC to Collaborate with Insmed on Brensocatib Study in Bronchiectasis

    Bronchiectasis Brensocatib EMBARC Insmed Collaboration Interventional Study
  • BRIEF

    published on 06/25/2026 at 11:10, 4 months 22 days ago

    EMBARC va collaborer avec Insmed sur une étude concernant le brensocatib dans la bronchectasie.

    Bronchectasie Brensocatib EMBARC Collaboration Insmed Étude Interventionnelle
  • PRESS RELEASE

    published on 06/25/2026 at 11:05, 4 months 22 days ago

    EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis

    EMBARC announces collaboration with Insmed on landmark interventional study evaluating disease modification potential of brensocatib in bronchiectasis. Study aims to enroll 3,000 patients across Europe
    Bronchiectasis EMBARC Interventional Study Insmed Disease Modification
    Logo of EMBARC
Accesswire
  • Published on 11/17/2026 at 23:40, 47 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 11/17/2026 at 23:00, 1 hour 27 minutes ago

    Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline

  • Published on 11/17/2026 at 21:30, 2 hours 57 minutes ago

    Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction

  • Published on 11/17/2026 at 15:00, 9 hours 27 minutes ago

    Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry

  • Published on 11/17/2026 at 14:45, 9 hours 42 minutes ago

    NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)

View all ACCESSWIRE
EQS Group
  • Published on 11/17/2026 at 23:13, 1 hour 13 minutes ago

    EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%

  • Published on 11/17/2026 at 22:00, 2 hours 27 minutes ago

    Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

  • Published on 11/17/2026 at 21:12, 3 hours 14 minutes ago

    EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance

  • Published on 11/17/2026 at 20:21, 4 hours 6 minutes ago

    Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

  • Published on 11/17/2026 at 20:00, 4 hours 27 minutes ago

    EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027

View all EQS
Les Echos
  • Published on 11/17/2026 at 18:00, 6 hours 27 minutes ago

    20261117 - Accor - Accor to increase its stake in Ennismore

  • Published on 11/17/2026 at 18:00, 6 hours 27 minutes ago

    Accor - Accor se renforce au capital de Ennismore

  • Published on 11/17/2026 at 17:45, 6 hours 42 minutes ago

    EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP

  • Published on 11/17/2026 at 17:45, 6 hours 42 minutes ago

    EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP

  • Published on 11/17/2026 at 07:40, 16 hours 46 minutes ago

    SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy